What does the future hold for virtual fitness? A hybrid model, possibly

Stock prices for companies like Peloton and Zoom have soared in recent months.

On Monday, Zoom and Peloton took a hit after news of the effectiveness of a vaccine from the drug maker Pfizer, with investors hoping more people would start doing things outside their homes sooner than originally anticipated. Throughout the week, Zoom and Peloton’s prices crept up steadily after the complexities and challenges of getting a vaccine to the general public were revealed.

This week, as part of ABC’s “Perspective” podcast, ABC’s Daria Albinger spoke with Dave Packles, the irector of Product at Peloton, and Austin Cohen, the CEO of the app FlexIt, on what working out from home will look like once people resume normal activities.

PHOTO: Stock photo

“People have been treating fitness as a meeting,” Cohen said. “They have a thirty minute meeting. They go workout virtually for thirty minutes. They go back to their desk. Right? And then one hour past that first meeting that they had, and they’re back to work… It’s easy. It’s beautiful. You don’t waste time commuting to the gym.”

Packles said people have adjusted after months of training in their houses.

“In reality, people are being introduced to this [home workouts] for the first time. The norm was: ‘To get a workout in, I must go to a gym. I must go to a boutique class.’ Working out from home wasn’t as widespread. I think the pandemic is forcing people to kind of re-examine that. So you kind of have more people who are now trying it.”

Packles also said Peloton tries to tailor its workouts to different types of exercises, not just indoor bike riding, because people generally prefer to diversify their training and work out more than just by themselves.

“Working out in the physical presence of another person is always going to be the best,” Packles told ABC’s “Perspective” podcast. “Going for an outdoor ride with a friend, potentially going to a boutique class or going to the Peloton studio and feeling the energy of the people around you in the room? That’s always going to be such an amazing experience.”

“I think Peloton aims to try to capture the best things of that and bring that to them,” Packles added.

Cohen said the trend has even driven demand for a new job, the virtual trainer. However, he does not believe it will make gyms a thing of the past.

“Even if you’re not standing next to someone physically, they can still effectively be in your presence, motivate you, and hold you accountable. It’s a trend that we’re going to continue to see and

Read More

Will the traditional model of fitness centres get back to normal by 2021?

a group of people standing on a stage: The brick-and-mortar gyms were among the hardest hit at the onset of the pandemic. (Photo source: IE)

© Provided by The Financial Express
The brick-and-mortar gyms were among the hardest hit at the onset of the pandemic. (Photo source: IE)

By Prateek Sood

If we have to name a few industries that are badly affected by the pandemic and resultant lockdown, fitness centres are one of them. Now that gyms have resumed operations; industry experts and gyms owners are curious as well as hopeful of business getting back on track.

After gyms and fitness centres were forced to shut down earlier this year, fitness enthusiasts found alternatives to continue their fitness regime. This includes at-home gyms, yoga and online fitness classes. Even as gyms slowly begin to welcome back guests, at-home gyms are expected to remain a mainstay in personal fitness. This raises the concern about the future of gyms and those who run the business.

The Pandemic Impact and Struggle

The brick-and-mortar gyms were among the hardest hit at the onset of the pandemic. Though we cannot predict pandemic’ long term impacts on the industry, short term impacts have been catastrophic to many – massive crisis of unemployment of professional trainers, gyms and studio owners, and supporting staff. Many fitness centres, especially the boutique gyms found it difficult to pay bank electricity bills, rents, loans, and salaries of employees as a result of which many shutdown their operations.

The Way Forward

The growing influence of the digital world has called disruption in fitness industry as well. Virtual Gyms are making fitness resources available to the user in the comfort of their location. However, like any other challenge that comes with the internet, online fitness classes can lead to adverse health outcomes if the exercise is not done right as there is no expert to supervise. It is surely not a good option for beginners. While at the gym, one is recommended exercises according to their body, however, virtual classes don’t provide personalized training and the ones that do are very expensive.

As uncertainty prevails, there is an ever increasing need for the industry to develop itself with the changing times as many have already started doing so by going digital and creative. The digital transformation seems to be the best survival technique and stay relevant not only today but even in the future as technology continues to disrupt all the industries. As more people have opened up to the idea of working out from home, traditional gyms do face a challenge but they can deal with the situation by going digital and investing in the virtual model along with traditional gyms. This will create a comprehensive business model and give people a choice to choose what they find safe and comfortable.

However, the situation is alarming for the smaller players who have less budget to go virtual or invest in creating a digital platform. They might go for collaboration, funding or use traditional means of advertising to assure gym users’ safety and hygiene. One thing is certain, fitness centres that follow all safety and hygiene measures

Read More

Who Gets COVID-19 Vax Next: Model Offers ACIP Several Options

It’s generally agreed that healthcare workers should be first in line for COVID-19 vaccines. Who comes next, however, may depend on whether the goal is to prevent infections or deaths, according to a presentation at the CDC’s Advisory Committee on Immunization Practices (ACIP) on Friday.

A modeling study found that prioritizing adults ages 65 and older would avert more COVID-19 deaths, but prioritizing adults with high-risk medical conditions and essential workers would avert more COVID-19 infections, said Matthew Biggerstaff, ScD, of the CDC.

“Timing of the campaign is a really important factor in the potential impact of the vaccine,” he said at the ACIP meeting dedicated to COVID-19, describing three scenarios when the vaccine is distributed: before incidence rises, as incidence rises, or as incidence falls.

Not only that, but the type of vaccine plays a role, whether infection-blocking, meaning it will help stop transmission of the virus, or disease-blocking, meaning it will help reduce severity of illness, but have no bearing on whether people get infected.

ACIP will be responsible for ultimately deciding which populations receive the vaccine once the FDA approves a COVID-19 vaccine, likely under emergency use authorization (EUA). Previous proposals stated that healthcare workers would be vaccinated in in phase 1a, while phase 1b would take in essential workers” and adults ages 65 and older and those with high-risk medical conditions such as COPD, heart disease, diabetes and kidney disease.

Biggerstaff explained that his group’s models assumed 180 million initial doses of vaccine would be available, with 20 million of those allocated to healthcare personnel. Each modeling scenario then looked at two-dose vaccine courses allocated exclusively to each one of the phase 1b populations, followed by wider availability to the unvaccinated groups in each scenario.

They assumed a vaccine efficacy of 70%, with the first dose at a quarter of full protection, or 17.5%. Protection was assumed 14 days following vaccination. (Notably, though, the FDA has said it will consider vaccines with efficacy as low as 50%.)

The models assumed 15% of the population was infected 2 months prior to vaccine introduction and examined infections and deaths averted 6 months following vaccine introduction.

In this case, earlier introduction of vaccine was better in all scenarios, with vaccine introduced “before incidence rises” having the greatest impact.

The model with the greatest impact on infection was an infection-blocking vaccine, where vaccinating high-risk adults averted about 5% more cases of infection than vaccinating adults age 65 and older in a scenario before disease incidence rises.

However, an infection-blocking vaccine where older adults were vaccinated first averted about 4% more deaths than vaccinating high-risk adults first. This assumed full protection from the vaccine, there was no difference when the vaccine only provided older adults half protection.

A sensitivity analysis examined a disease-blocking vaccine where older adults were vaccinated first, in a scenario where a vaccine is introduced before incidence rises, would avert 11% more deaths.

Expanded Access Versus EUA

Doran Fink, MD, PhD, of FDA’s Office of Vaccines Research and

Read More

Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2030 – Focus on the Supply Chain Model of Medical Isotope Mo-99 (Tc-99m)

DUBLIN, Oct. 21, 2020 /PRNewswire/ — The “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report has been added to’s offering.

The ‘Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030’ report provides a detailed study on the current market landscape and future potential of the companies having the capabilities to manufacture radiopharmaceuticals. In addition, the study features an in-depth analysis, highlighting the capabilities of a diverse set of industry stakeholders.

Over the years, medical research teams across the world have gradually tapped into the vast potential of radiopharmaceuticals and nuclear medicines. In fact, the technology that is now used in this field is reported to have witnessed significant evolution, in terms of technological sophistication. As a result, the demand for such specialized chemicals has grown at an exponential rate.

However, the development and production of radiopharmaceuticals is inherently complex, and requires specialized facilities and operational expertise. Therefore, acquiring the necessary technical acumen and infrastructure to support such operations is not a feasible option for pharmaceutical companies, owing to a number of associated clauses and concerns (such as need for high capital investments, unique operating licenses and compliance to special regulatory requirements).

Scope Of the Report

  • A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals. It features information on the year of establishment, company size, purpose of production (fulfilling in-house requirements / for contract services), location of headquarters, location of manufacturing facilities, scale of production, applications of radiopharmaceuticals (in diagnosis, therapeutics and theranostics), type of diagnostic radiopharmaceuticals (PET and SPECT), type of therapeutic radiopharmaceuticals (alpha emitters, beta emitters and others), target therapeutic area (cardiology, oncology, neurology, thyroid and others) and services offered.
  • An insightful four-dimensional comparison of the radiopharmaceutical manufacturers, based on supplier power (year of establishment), product portfolio (number of isotopes being manufactured for various applications targeting different therapeutic areas) of the manufacturer, scale at which they manufacture their respective products and company size.
  • Tabulated profiles of key industry players based in North America, Europe and Asia-Pacific (shortlisted based on the company size of the players), featuring a brief overview of the company, a list of products and manufacturing facilities, recent developments and an informed future outlook.
  • An analysis of recent partnerships and collaborations inked in this domain since 2017, based on several parameters, such as the type of partnership, year of partnership, type of radioisotope involved, therapeutic area mentioned in the agreement, application of the radioisotope mentioned in the agreement, and a schematic representation showcasing the players that have forged the maximum number of alliances. Furthermore, we have provided a world map representation of the deals inked in this field, highlighting those that have been established within and across different continents.
  • A detailed discussion on the supply chain model of medical isotope Mo-99 (Tc-99m), highlighting the main steps of the supply chain, from irradiation of uranium targets in nuclear research reactors to the administration of Tc-99m to patients. Along with this, it describes the structure of the
Read More

Key coronavirus model predicts nearly 80 percent rise in deaths by February

A key model foresees approximately 171,000 more coronavirus related deaths by February 2021, a number that would represent a spike of 78 percent.

The model from the Institute for Health Metrics and Evaluation at the University of Washington School of Medicine suggests there will be roughly 389,087 deaths by Feb. 1.

If all Americans use face masks, the model’s best-case scenario projects 314,000 deaths by that date. The model, however, foresees more than 477,000 deaths if mask mandates are eased.

“We expect deaths to stop declining and begin increasing in the next one to two weeks,” researchers said, according to CNN. “The winter surge appears to have begun somewhat later than the surge in Europe. Daily deaths will reach over 2,000 a day in January even with many states reimposing mandates before the end of the year.”

As of Thursday morning, the United States is now averaging approximately 52,345 new daily cases, an increase of 16 percent from the previous week. 

An analysis of COVID-19 data from Johns Hopkins University reveals that 21 states are recording a peak of weekly averages of new cases since the onset of the pandemic, CNN reported

The states seeing record increases in new cases include Alaska, Colorado, Idaho, Illinois, Indiana, Kansas, Kentucky, Minnesota, Missouri, Montana, Nebraska, New Mexico, North Dakota, Ohio, Oklahoma, Oregon, South Dakota, Utah, West Virginia, Wisconsin and Wyoming.

Public health experts are warning that rising cases will continue to spike as the weather cools and people move indoors. 

Anthony FauciAnthony FauciTrump fields questions on coronavirus, conspiracy theories in combative town hall Chris Christie says he ‘was wrong’ not to wear face mask at White House Overnight Health Care: Georgia gets Trump approval for Medicaid work requirements, partial expansion | McConnell shoots down .8 trillion coronavirus deal MORE, the government’s top infectious disease expert, on Thursday warned that American families should “evaluate the risk-benefit” of having a Thanksgiving gathering with regard to spreading coronavirus. 

“We really have to be careful this time, and each individual family evaluate the risk-benefit of doing that, particularly when you have people coming in from out of town who may have been on airplanes, in airports,” Fauci said.

He called the current situation in the U.S. “quite concerning [and] we’ve really got to double down on the fundamental public health measures that we talk about every single day because they can make a difference.”

Source Article

Read More